The incremental cost of disease progression among patients with metastatic stage IIIB or IV non-small cell lung cancer versus those without progression was $12,327 for 3 postprogression months.
Kathleen M. Fox, MHS, PhD
Advertisement
Articles by Kathleen M. Fox, MHS, PhD
Advertisement
Latest Updated Articles
- Metastatic Non–Small Cell Lung Cancer: Costs Associated With Disease Progression
Published: September 15th 2008 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
Measles Outbreaks Cause Financial, Public Health Burden in US
3
Immunotherapy's Evolving Role in Ovarian Cancer: Nicoletta Colombo, MD, PhD
4
Boosting RSV Vaccination in Older Adults Could Save Thousands
5
